Abstract
The application of noninvasive imaging techniques to assess myocardial viability has become an important part of routine management of patients with acute myocardial infarction and chronic coronary artery disease. Information regarding the presence and extent of viability may help identify patients likely to benefit from revascularization or therapy directed at attenuating left ventricular remodeling. Myocardial contrast echocardiography (MCE) is capable of defining the presence and extent of viability by providing an accurate assessment of microvascular integrity needed to maintain myocellular viability. It is especially suited for the spatial assessment of perfusion, even when myocardial blood flow is reduced substantially in the presence of severe epicardial stenoses or in a bed dependent on collateral perfusion. The routine use of MCE to evaluate viability in patients with acute and chronic coronary artery disease is now feasible with the advent of new imaging technologies and microbubble agents capable of myocardial opacification from venous injections. The utility of this technique for determining treatment strategies has not been established but is forthcoming.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 417-425 |
| Number of pages | 9 |
| Journal | Echocardiography |
| Volume | 19 |
| Issue number | 5 |
| State | Published - Jul 2002 |
| Externally published | Yes |
Fingerprint
Keywords
- Congestive heart failure
- Coronary artery disease
- Myocardial contrast echocardiography
- Myocardial viability
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
Cite this
Assessment of myocardial viability with myocardial contrast echocardiography. / Lindner, Jonathan.
In: Echocardiography, Vol. 19, No. 5, 07.2002, p. 417-425.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Assessment of myocardial viability with myocardial contrast echocardiography
AU - Lindner, Jonathan
PY - 2002/7
Y1 - 2002/7
N2 - The application of noninvasive imaging techniques to assess myocardial viability has become an important part of routine management of patients with acute myocardial infarction and chronic coronary artery disease. Information regarding the presence and extent of viability may help identify patients likely to benefit from revascularization or therapy directed at attenuating left ventricular remodeling. Myocardial contrast echocardiography (MCE) is capable of defining the presence and extent of viability by providing an accurate assessment of microvascular integrity needed to maintain myocellular viability. It is especially suited for the spatial assessment of perfusion, even when myocardial blood flow is reduced substantially in the presence of severe epicardial stenoses or in a bed dependent on collateral perfusion. The routine use of MCE to evaluate viability in patients with acute and chronic coronary artery disease is now feasible with the advent of new imaging technologies and microbubble agents capable of myocardial opacification from venous injections. The utility of this technique for determining treatment strategies has not been established but is forthcoming.
AB - The application of noninvasive imaging techniques to assess myocardial viability has become an important part of routine management of patients with acute myocardial infarction and chronic coronary artery disease. Information regarding the presence and extent of viability may help identify patients likely to benefit from revascularization or therapy directed at attenuating left ventricular remodeling. Myocardial contrast echocardiography (MCE) is capable of defining the presence and extent of viability by providing an accurate assessment of microvascular integrity needed to maintain myocellular viability. It is especially suited for the spatial assessment of perfusion, even when myocardial blood flow is reduced substantially in the presence of severe epicardial stenoses or in a bed dependent on collateral perfusion. The routine use of MCE to evaluate viability in patients with acute and chronic coronary artery disease is now feasible with the advent of new imaging technologies and microbubble agents capable of myocardial opacification from venous injections. The utility of this technique for determining treatment strategies has not been established but is forthcoming.
KW - Congestive heart failure
KW - Coronary artery disease
KW - Myocardial contrast echocardiography
KW - Myocardial viability
UR - http://www.scopus.com/inward/record.url?scp=0036633195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036633195&partnerID=8YFLogxK
M3 - Article
C2 - 12174206
AN - SCOPUS:0036633195
VL - 19
SP - 417
EP - 425
JO - Echocardiography
JF - Echocardiography
SN - 0742-2822
IS - 5
ER -